Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Emory University | 20 |
| 2 | BioNTech SE | 14 |
| 3 | Government of the United States of America | 9 |
| 4 | Astellas Pharma Inc | 8 |
| 5 | Verinos Pharmaceuticals GmbH | 7 |
| 6 | Centre National de la Recherche Scientifique | 5 |
| 7 | C.H. Boehringer Sohn AG and Co KG | 4 |
| 8 | Capital Medical University | 4 |
| 9 | Universiteit Maastricht | 4 |
| 10 | Cincinnati Children's Hospital Medical Center | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 119 |
| 2 | A61P | Therapeutic activity (drug indications) | 113 |
| 3 | C07K | Peptides | 35 |
| 4 | C12N | Microorganisms, enzymes | 31 |
| 5 | C07D | Heterocyclic compounds | 24 |
| 6 | G01N | Investigating / analysing materials | 19 |
| 7 | C12Q | Measuring/testing involving enzymes | 16 |
| 8 | A61Q | Cosmetics, personal care | 12 |
| 9 | Y02A | Climate change adaptation | 12 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 10 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | 2022 | Emory University | 16 |
| QUINAZOLINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | 2012 | Emory University | 48 |
| MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | 2022 | Emory University | 13 |
| THIONUCLEOSIDES AS ANTIVIRAL AGENTS | 2022 | Emory University | 12 |
| FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE | 2020 | Metacrine Inc | 16 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 5 |
| 2023 | 1 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Xiu‐Ju Luo | Central South University | 3 |
| 2 | Patricia I. Oteiza | University of California, Davis | 3 |
| 3 | Daniel R. González | University of Talca | 2 |
| 4 | Zhong‐Song Shi | The First Affiliated Hospital, Sun Yat-sen University | 2 |
| 5 | Н. В. Гончаров | Institute of Evolutionary Physiology and Biochemistry | 2 |
| 6 | Lei Feng | Kaiser Permanente | 2 |
| 7 | Raúl A Dulce | University of Miami | 2 |
| 8 | Mingchang Li | Wuhan University | 2 |
| 9 | Maria Wartenberg | University of Cologne | 2 |
| 10 | Yong-Hua Tuo | The First Affiliated Hospital, Sun Yat-sen University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| RETRACTED ARTICLE: NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages | 2016 | 291 | Inflammasome and immune disorders |
| Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation☆ | 2006 | 255 | Nitric Oxide and Endothelin Effects |
| NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage | 2017 | 158 | Nitric Oxide and Endothelin Effects |
| Glutathione Peroxidase-1 Deficiency Potentiates Dysregulatory Modifications of Endothelial Nitric Oxide Synthase and Vascular Dysfunction in Aging | 2013 | 135 | Nitric Oxide and Endothelin Effects |
| Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation | 2014 | 125 | Adipokines, Inflammation, and Metabolic Diseases |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical structure and molecular formula of VAS2870?
Which organizations hold the most patents related to VAS2870?
What is the patent and publication trend for VAS2870 research?
What are the main research topics associated with VAS2870?
Which patent classifications dominate VAS2870-related intellectual property?